CCL19 emerges as a promising biomarker that distinguishes active disease from treatment-induced remission and may help to identify relapsing disease in patients with IgG4-related disease.
Medscape Medical News
Source link : https://www.medscape.com/viewarticle/ccl19-biomarker-may-track-disease-activity-igg4-related-2026a1000jdy?src=rss
Author :
Publish date : 2026-06-10 09:04:00
Copyright for syndicated content belongs to the linked Source.
